Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment
about
Post-exposure prophylaxis for SIV revisited: animal model for HIV preventionModeling the within-host dynamics of HIV infectionSafety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workersEfficacy of Carraguard-based microbicides in vivo despite variable in vitro activityAlphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone ® in rhesus macaquesDeveloping Combined HIV Vaccine Strategies for a Functional CureSIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humansAAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing ActivityAnti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infectionPolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In VivoA macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacyAn antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaquesSang Froid in a time of trouble: is a vaccine against HIV possible?Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gelT cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxisMassive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infectionEvolutionary dynamics of HIV at multiple spatial and temporal scales.Going wild: lessons from naturally occurring T-lymphotropic lentivirusesGeneration and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.Multivariate statistical analyses demonstrate unique host immune responses to single and dual lentiviral infection.Distribution, persistence, and efficacy of adoptively transferred central and effector memory-derived autologous simian immunodeficiency virus-specific CD8+ T cell clones in rhesus macaques during acute infection.Trafficking, persistence, and activation state of adoptively transferred allogeneic and autologous Simian Immunodeficiency Virus-specific CD8(+) T cell clones during acute and chronic infection of rhesus macaquesProton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDSCD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.CD4 T cell subsets in the mucosa are CD28+Ki-67-HLA-DR-CD69+ but show differential infection based on alpha4beta7 receptor expression during acute SIV infection.Evidence of early B-cell dysregulation in simian immunodeficiency virus infection: rapid depletion of naïve and memory B-cell subsets with delayed reconstitution of the naïve B-cell population.Systemic dendritic cell mobilization associated with administration of FLT3 ligand to SIV- and SHIV-infected macaques.Similar impact of CD8+ T cell responses on early virus dynamics during SIV infections of rhesus macaques and sooty mangabeys.Retroviral recombination in vivo: viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239Deltavpx/Deltavpr and SIIncreased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma.Elevated numbers of CD163+ macrophages in hearts of simian immunodeficiency virus-infected monkeys correlate with cardiac pathology and fibrosis.Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaquesImmunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDSLow human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.Experimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication.Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virusTransduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication.Optimal antiviral switching to minimize resistance risk in HIV therapy.
P2860
Q21245029-76762F01-94B2-44D7-8C89-72AFAE35466BQ21245370-9209A661-F056-4A84-B185-9FDE58EC3DA3Q21558500-CA711527-E6FF-4B7B-B294-C026CE6DD9DCQ21562543-DB9CBBE8-13B3-4E52-B1EB-6BAD112E0816Q24633851-F4A7F8BF-8E66-4C43-8843-3713E95A878DQ26998898-CA334B76-1F9E-43C4-BDD9-49834BC2BA74Q27014903-753453EA-D0B2-4841-8617-F91C57C19B35Q27318266-0A2D2073-E43E-45B3-B521-E7954BC0435AQ27322602-8613B6AC-70D2-4FCA-A158-67567C59C6BDQ27324710-330171B4-2A28-40F6-ADBB-F6E2EE34A37FQ27335068-1C06C663-E420-4BB0-A1AC-72ADFA5A44A4Q27438093-F49C8749-0382-432B-8BE2-5AEC7FD90A88Q27487961-1C2379F4-268B-4404-A553-390903D341EEQ28473376-29923CFE-B500-4EAB-A0C8-B96A86774C24Q28477909-F2359CFE-C321-492D-8CEC-0246F7F7C261Q29619124-0A611D45-CFD2-4035-9CFA-004D1D180EA4Q30416280-410E56FF-40D1-407F-9815-20D93D8D6B52Q31066870-14DA684C-959A-4504-9214-BD19BB3A0649Q31106756-6624ADFB-6402-4303-9C06-F270B8B2D73EQ33508836-42A9087E-23E0-488A-A91B-74AD227CBE86Q33554940-121BCE75-8CF0-436B-B7AA-C39E81B270E4Q33554963-6324A729-3F40-4276-8228-FC16A4FB1F8DQ33580220-79933E5B-B550-4C22-86C8-7B0869FE98DCQ33618007-7E914E2D-A818-43A6-83DB-51EF268F7BDEQ33619083-BD208FB1-45EA-4B2C-A768-0236373C8C3BQ33648998-37F0CFA8-39F8-44BA-8DCE-2A893FC2F7B7Q33686549-D6933DD6-15BE-4EBE-96D8-60D7B007574BQ33701593-79B9DA8F-F67A-4AA5-8518-E6E216FC8127Q33724189-60D185F7-F26E-49C0-9990-5372F3056AF1Q33792327-145A4B00-80C5-4FF6-AF84-5A5EF46A1061Q33828245-2D4E835C-6E11-41C2-ACBC-40FB02D94D63Q33841288-5B149BA7-E3CD-4204-8741-B69D76ECA65BQ33843131-DD3C3A00-803A-452B-BB8C-C2757D7DD078Q33873798-F622F5D9-1697-4124-9750-8B1AD0AE84BBQ33883813-3318CA2E-9A65-4096-ACA9-70DB7C5E0C81Q33888012-2115BA7D-9830-416C-A204-19848D86107AQ33919945-9BC32D77-5354-4FF3-8ABA-3DAD76E99C48Q33984208-1E767B29-5C65-4619-9E27-C06778EB6B9CQ34008900-EE099C96-282A-4A72-86D8-75956A47B5CFQ34071754-0BB31AE8-0659-4720-BFB5-F254D0A322B0
P2860
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Role of CD8(+) lymphocytes in ...... early antiretroviral treatment
@ast
Role of CD8(+) lymphocytes in ...... early antiretroviral treatment
@en
type
label
Role of CD8(+) lymphocytes in ...... early antiretroviral treatment
@ast
Role of CD8(+) lymphocytes in ...... early antiretroviral treatment
@en
prefLabel
Role of CD8(+) lymphocytes in ...... early antiretroviral treatment
@ast
Role of CD8(+) lymphocytes in ...... early antiretroviral treatment
@en
P2093
P2860
P1433
P1476
Role of CD8(+) lymphocytes in ...... early antiretroviral treatment
@en
P2093
J D Lifson
J L Rossio
K A Reimann
P2860
P304
10187-10199
P356
10.1128/JVI.75.21.10187-10199.2001
P577
2001-11-01T00:00:00Z